These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 11034401)

  • 1. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung.
    LeVine AM; Whitsett JA; Gwozdz JA; Richardson TR; Fisher JH; Burhans MS; Korfhagen TR
    J Immunol; 2000 Oct; 165(7):3934-40. PubMed ID: 11034401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
    LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
    Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.
    LeVine AM; Bruno MD; Huelsman KM; Ross GF; Whitsett JA; Korfhagen TR
    J Immunol; 1997 May; 158(9):4336-40. PubMed ID: 9126996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.
    LeVine AM; Kurak KE; Wright JR; Watford WT; Bruno MD; Ross GF; Whitsett JA; Korfhagen TR
    Am J Respir Cell Mol Biol; 1999 Feb; 20(2):279-86. PubMed ID: 9922219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
    Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.
    LeVine AM; Reed JA; Kurak KE; Cianciolo E; Whitsett JA
    J Clin Invest; 1999 Feb; 103(4):563-9. PubMed ID: 10021465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
    Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
    J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice.
    Hawgood S; Akiyama J; Brown C; Allen L; Li G; Poulain FR
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1148-56. PubMed ID: 11350793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A.
    Herting E; Strayer DS; Jarstrand C; Sun B; Robertson B
    Lung; 1998; 176(2):123-31. PubMed ID: 9500297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung.
    Wang X; Moser C; Louboutin JP; Lysenko ES; Weiner DJ; Weiser JN; Wilson JM
    J Immunol; 2002 Jan; 168(2):810-5. PubMed ID: 11777976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.
    Wert SE; Yoshida M; LeVine AM; Ikegami M; Jones T; Ross GF; Fisher JH; Korfhagen TR; Whitsett JA
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5972-7. PubMed ID: 10801980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.
    LeVine AM; Whitsett JA; Hartshorn KL; Crouch EC; Korfhagen TR
    J Immunol; 2001 Nov; 167(10):5868-73. PubMed ID: 11698462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary collectins and innate host defense of the lung.
    LeVine AM; Whitsett JA
    Microbes Infect; 2001 Feb; 3(2):161-6. PubMed ID: 11251302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.
    LeVine AM; Gwozdz J; Stark J; Bruno M; Whitsett J; Korfhagen T
    J Clin Invest; 1999 Apr; 103(7):1015-21. PubMed ID: 10194474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection.
    Harrod KS; Trapnell BC; Otake K; Korfhagen TR; Whitsett JA
    Am J Physiol; 1999 Sep; 277(3):L580-8. PubMed ID: 10484466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D.
    Botas C; Poulain F; Akiyama J; Brown C; Allen L; Goerke J; Clements J; Carlson E; Gillespie AM; Epstein C; Hawgood S
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11869-74. PubMed ID: 9751757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways.
    Yoshida M; Korfhagen TR; Whitsett JA
    J Immunol; 2001 Jun; 166(12):7514-9. PubMed ID: 11390505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection.
    LeVine AM; Hartshorn K; Elliott J; Whitsett J; Korfhagen T
    Am J Physiol Lung Cell Mol Physiol; 2002 Mar; 282(3):L563-72. PubMed ID: 11839553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein D reduces alveolar macrophage apoptosis in vivo.
    Clark H; Palaniyar N; Strong P; Edmondson J; Hawgood S; Reid KB
    J Immunol; 2002 Sep; 169(6):2892-9. PubMed ID: 12218102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages.
    Tino MJ; Wright JR
    Am J Physiol; 1996 Apr; 270(4 Pt 1):L677-88. PubMed ID: 8928829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.